반응식
[CH3:1][NH:2][C@@H:3]1[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[C@H:6]([C:13]2[CH:14]=[CH:15][C:16]([Cl:20])=[C:17]([Cl:19])[CH:18]=2)[CH2:5][CH2:4]1>C1(C)C=CC=CC=1>[CH3:1][NH:2][C@@H:3]1[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[C@H:6]([C:13]2[CH:14]=[CH:15][C:16]([Cl:20])=[C:17]([Cl:19])[CH:18]=2)[CH2:5][CH2:4]1.[ClH:19]참가 물질
3
시약·촉매·용매 1
실험 절차
Sertraline base (5.8 g) was dissolved in toluene (200 mL). Gaseous hydrochloric acid was bubbled (about pH 1.5) through the solution to induce the formation of sertraline hydrochloride Form XVI. The solution gelled while it was being acidified but remained stirrable. Filtration and drying at 50° C. for 16 hours yields sertraline hydrochloride Form XVI (6.61 gr.).
후처리
- customGaseous hydrochloric acid was bubbled (about pH 1.5) through the solution
- filtrationFiltration
- customdrying at 50° C. for 16 hours
출처 및 근거
- ORD 기록
- ord-9ee4cd5e050c42d7ab043c502bf67170
- 출처 데이터셋
- uspto-grants-2005_02
- 특허 번호
- US06858652B2
연결된 노트
불러오는 중…